MetLife (MET)

Cost of Revenue

$58.55B

TTM · Period ending: · USD

MET logo

MET Cost of Revenue

Latest reported$58.55B
MET TTM Cost of Revenue ($0.00 → $58.55B)
High-resolution chart · PNG

MET cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

MetLife Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
58,550,000,000
55,095,000,000
56,666,000,000
53,698,000,000
52,605,000,000
53,072,000,000
50,940,000,000
53,218,000,000
53,575,000,000
54,572,000,000
56,239,000,000
52,897,000,000
58,553,000,000
56,951,000,000
55,339,000,000
59,388,000,000
53,412,000,000
53,013,000,000
54,758,000,000
55,154,000,000
55,345,000,000
55,069,000,000
52,373,000,000
50,170,000,000
50,664,000,000
51,661,000,000
53,431,000,000
49,623,000,000
48,782,000,000
53,547,000,000
52,041,000,000
54,494,000,000
55,054,000,000
49,368,000,000
50,115,000,000
49,253,000,000
47,902,000,000
48,224,000,000
49,018,000,000
49,115,000,000
49,608,000,000
49,292,000,000
49,581,000,000
50,477,000,000
50,769,000,000
51,993,000,000
51,564,000,000
51,618,000,000
51,074,000,000
50,266,000,000
51,065,000,000
50,558,000,000
50,553,000,000
49,771,000,000
49,298,000,000
46,810,000,000
44,389,000,000
43,413,000,000
41,069,000,000
90,360,000,000
89,177,000,000
86,592,000,000
85,037,000,000
82,698,000,000
65,694,000,000
49,541,000,000
33,185,000,000
-16,180,000,000
-16,142,000,000
-15,742,000,000
-15,808,000,000
-14,070,000,000
2,788,000,000
3,230,000,000
19,195,000,000
18,649,000,000
19,167,000,000
34,999,000,000
35,298,000,000
34,561,000,000
34,583,000,000
33,890,000,000
32,853,000,000
30,949,000,000
29,312,000,000
28,385,000,000
27,878,000,000
27,663,000,000
26,211,000,000
25,063,000,000
23,859,000,000
23,404,000,000
22,963,000,000
22,841,000,000
22,473,000,000
22,279,000,000
22,272,000,000
21,675,000,000
21,538,000,000
22,788,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.